Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BMS-986458 by Bristol-Myers Squibb for Follicular Lymphoma: Likelihood of Approval
BMS-986458 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase...
Data Insights
BMS-986458 by Bristol-Myers Squibb for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
BMS-986458 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to...